TherapeuticsMD, Inc. (TXMD)
USD 1.1
(-3.51%)
USD 1.1
(-3.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -48.14 Million | -4.07 Million | -142.69 Million | -159.47 Million | -165.69 Million | -106.81 Million |
| Net Income | -10.27 Million | 1.07 Million | -172.41 Million | -183.52 Million | -176.14 Million | -132.61 Million |
| Depreciation & Amortization | 122 Thousand | 1.19 Million | 4.09 Million | 4.06 Million | 1.39 Million | 293.88 Thousand |
| Deferred income taxes | 2.13 Million | - | 533 Thousand | 1.75 Million | 10.44 Million | 216.02 Thousand |
| Stock-based compensation | 1.27 Million | 11.57 Million | 18.12 Million | 10.67 Million | 10.68 Million | 8.66 Million |
| Change in working capital | -15.31 Million | -4.08 Million | -520 Thousand | -3.31 Million | -14 Million | 16.36 Million |
| Other non-cash items | -23.94 Million | -13.83 Million | 7.49 Million | 10.86 Million | 1.91 Million | 269.85 Thousand |
| Investing Cash Flow | - | 223.47 Million | -2.22 Million | -1.59 Million | -23.91 Million | -21.49 Million |
| Investments in PPE | - | -355 Thousand | -2.22 Million | -1.59 Million | -23.89 Million | -21.32 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 223.83 Million | -2.18 Million | -1.39 Million | -20.42 Thousand | -175.41 Thousand |
| Financing Cash Flow | 3.15 Million | -235.2 Million | 129.55 Million | 80.72 Million | 188.82 Million | 162.78 Million |
| Debt repayment | - | -219.43 Million | -50 Million | -48.75 Million | -81.66 Million | -71.21 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -38.65 Million | - | - | - | - |
| Common Stock Issuance | 3.15 Million | 24.15 Million | 184.11 Million | 31.7 Million | 77.03 Million | 89.9 Million |
| Other Financing Activities | 3.15 Million | -15.77 Million | -4.56 Million | 97.77 Million | 193.45 Million | 72.87 Million |
| Accounts receivables | - | - | -4.32 Million | -8.19 Million | -13.63 Million | -6.95 Million |
| Accounts payables | -2.13 Million | -1.21 Million | -750 Thousand | 1.88 Million | -3.56 Million | 18.64 Million |
| Inventory | - | - | -711 Thousand | -3.33 Million | -8.59 Million | -1.78 Million |
| Other working capital | -15.31 Million | -2.87 Million | 5.26 Million | 6.33 Million | 11.79 Million | 6.45 Million |
| Cash at beginning of period | 49.31 Million | 65.12 Million | 80.48 Million | 160.82 Million | 161.61 Million | 127.13 Million |
| Cash at end of period | 4.32 Million | 49.31 Million | 65.12 Million | 80.48 Million | 160.82 Million | 161.61 Million |
| Capital Expenditure | - | -355 Thousand | -2.22 Million | -1.59 Million | -23.89 Million | -21.32 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -44.99 Million | -15.8 Million | -15.36 Million | -80.34 Million | -783.36 Thousand | 34.47 Million |
| Free Cash Flow | -48.14 Million | -4.43 Million | -144.91 Million | -161.06 Million | -189.58 Million | -128.13 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.05 Million | -809 Thousand | -1.54 Million | -7.69 Million | -1.43 Million | -2.41 Million |
| Depreciation & Amortization | 180 Thousand | 133 Thousand | 637 Thousand | 922 Thousand | 129 Thousand | 129 Thousand |
| Deferred income taxes | - | - | -2.05 Million | 2.13 Million | - | - |
| Stock-based compensation | 96 Thousand | 111 Thousand | 116 Thousand | 1.27 Million | 234 Thousand | 438 Thousand |
| Change in working capital | 776 Thousand | 150 Thousand | -3.45 Million | -17.44 Million | -5.56 Million | -1.52 Million |
| Other non-cash items | 1.34 Million | 691 Thousand | -1.53 Million | -19.93 Million | 603 Thousand | -18 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 2 Million | 3.15 Million | -1000.00 | 1.15 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 1000.00 | - | -1000.00 | - |
| Common Stock Issuance | - | - | 2 Million | 3.15 Million | -1000.00 | 1.15 Million |
| Other Financing Activities | - | - | 2 Million | 3.15 Million | -1.1 Million | 1000.00 |
| Accounts receivables | - | - | 19 Thousand | - | - | - |
| Accounts payables | 4000.00 | 112 Thousand | -669 Thousand | -2.13 Million | -812 Thousand | -818 Thousand |
| Inventory | - | - | 6.88 Million | - | - | - |
| Other working capital | 772 Thousand | 38 Thousand | -2.79 Million | -15.31 Million | -4.74 Million | -709 Thousand |
| Cash at beginning of period | 4.33 Million | 4.32 Million | 10.16 Million | 49.31 Million | 13.72 Million | 17.24 Million |
| Cash at end of period | 5.23 Million | 4.33 Million | 4.32 Million | 4.32 Million | 10.16 Million | 13.72 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 894 Thousand | 11 Thousand | -5.83 Million | -44.99 Million | -3.56 Million | -3.51 Million |
| Free Cash Flow | 894 Thousand | 11 Thousand | -7.84 Million | -48.14 Million | -6.02 Million | -3.39 Million |
JCKH
6210
SHAREINDIA
XPL
4109
6659